Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinpocetine (Cavinton Forte) in non-proliferative diabetic retinopathy
2008-005032-33Phase 4Completed
- Sponsor
- Gedeon Richter Plc
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nonproliferative diabetic retinopathy (NPDR) and diabetic retinopathy (DR) comparing Cavinton Forte (vinpocetine) with Placebo (2 arms). Primary endpoints: Exploratory efficacy parameters and Safety and tolerability. Started Oct 2008; status: completed.
02
Drugs
vinpocetine
03
Conditions
nonproliferative diabetic retinopathy (NPDR)diabetic retinopathy (DR)
Beyond the preview
Go deeper on 2008-005032-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005032-33.